Patent · US Active

Compounds for modulating TRPV3 function

US9486455B2 · kind B2 · utility

1Cited by

15References

13Claims

0Family size

Assignee

Hydra Biosciences, LLC · US

Inventors

Jayhong A. Chong · Brookline, US
Christopher Fanger · Bolton, US
Glenn R. Larsen · Sudbury, US
Magdalene M. Moran · Brookline, US
Howard P. Ng · El Sobrante, US
Amy Ripka · Reading, US
Dennis John Underwood · Brookline, US
Manfred Weigele · North Caldwell, US
Xiaoguang Zhen · New York, US

Key dates

Filing date	Mar 4, 2011
Grant date	Nov 8, 2016
Priority date	—
Expiry date	Mar 4, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.